Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
Molecular Cancer Therapeutics|December 24, 2005
In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlatesDouglas C Marchion, Elona Bicaku, Adil I Daud, et al.Cancer Research|May 4, 2005
Valproic acid alters chromatin structure by regulation of chromatin modulation proteinsDouglas C Marchion, Elona Bicaku, Adil I Daud, et al.Journal for Immunotherapy of Cancer|June 1, 2018
In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case seriesMelody J Xu, Susan Wu, Adil I Daud, et al.Hematology/Oncology Clinics of North America|March 24, 2021
Advanced Melanoma: Resistance Mechanisms to Current TherapiesAlexandra M Haugh, April K S Salama, Douglas B JohnsonJournal of Computer Assisted Tomography|January 20, 2011
Tumor fistulization associated with targeted therapy: computed tomographic findings and clinical consequencesHenry Chow, Adam Jung, Jason Talbott, et al.Journal of Cellular Biochemistry|April 27, 2004
Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acidDouglas C Marchion, Elona Bicaku, Adil I Daud, et al.Cancer Research|March 5, 2025
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in MelanomaKelly M Mahuron, Osmaan Shahid, Prachi Sao, et al.Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
Activated stat-3 in melanomaJane L Messina, Hua Yu, Adam I Riker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbetaDouglas C Marchion, Elona Bicaku, Joel G Turner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2021
The Liver-Immunity Nexus and Cancer ImmunotherapyJames C Lee, Michael D Green, Laura A Huppert, et al.Pageof 8